Ex Vivo Exploratory Analysis in Healthy Full-term Infants
NCT ID: NCT01573884
Last Updated: 2012-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
54 participants
OBSERVATIONAL
2011-09-30
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Characterization of the composition of maternal milk and infant urine
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human-derived Human Milk Fortifiers (H2MF), Gut Microbiota and Oxidative Stress in Premature Infants
NCT03214822
Growth and Tolerance of Young Infants
NCT03276884
Growth and Safety Clinical Trial on a New Infant Formula.
NCT04671576
BM Characterization Pilot
NCT03138057
Growth and Tolerance of Young Infants Fed Infant Formulas
NCT01380886
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infant or infant-mother pair is from smoke-free home
* Infant is a singleton, full term
* birth weight was \> 2490 g
* Between 0 and 17 days of age at enrollment
* Human milk fed infants must have been exclusively human milk-fed since birth; formula fed infants must have received Similac Advance or Similac Sensitive since birth
* Parents confirm their intention not to administer vitamin or mineral supplements (excluding vitamin or mineral supplements containing vitamin D), solid foods or juices to their infant from enrollment throughout the study
Exclusion Criteria
* Infant has been treated with antibiotics
* Participation in another study -
17 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen Goehring, MS
Role: STUDY_CHAIR
Abbott Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northpoint Pediatrics
Indianapolis, Indiana, United States
Institute of Clinical Research
Mayfield Heights, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AK97
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.